serum

  1. CDSCO panel approves continuation of Phase II clinical trials of SII's dengue vaccine

    New Delhi: An expert committee under the Central Drugs Regulatory Authority recommended continuation of Phase II clinical trials of Serum Institute of India (SII) vaccine against dengue after observing promising results of Phase I interim clinical trials. Is.Serum Institute conducted a...
  2. India, Denmark hold 4-day event to strengthen cooperation in the field of infectious diseases, one health approach

    New Delhi [India], India and Denmark on Monday began a four-day bilateral dialogue between the National Center for Disease Control (NCDC), Ministry of Health and Family Welfare, Government of India, and Statens Serum Institute (SSI), Ministry of Health and Family Welfare, Government of India...
  3. Reliance, Tata included in TIME's list of world's most influential companies

    New Delhi, Billionaire Mukesh Ambani's Reliance Industries and Tata Group have made it to the prestigious TIME's list of the world's 100 most influential companies in 2024. TIME has called Reliance 'India's Juggler'.This is the second time that Reliance has made its place in the TIME list. G...
  4. Tata Group, Serum Institute of India included in Time's list of world's top 100 most influential companies

    While Tata Group was included in the list under the 'Titans' category, Pune-based SII was part of the 'Pioneers' segment.“Founded in 1868, the Tata Group has long cemented its place in the Indian economy with its vast portfolio spanning steel, software, watches, undersea cables, chemicals to...
  5. Serum Institute of India sends first consignment of malaria vaccines to Africa

    Pune (Maharashtra) [India], In a major achievement, Serum Institute of India (SII) has shipped the first set of R21/Matrix-M malaria vaccine doses to the Africa region, where there is a high burden of the disease. The distribution of the malaria vaccine throughout the African region will be an...
  6. SII begins shipment of malaria vaccine 'R21/Matrix-M' to Africa

    New Delhi, Vaccine maker Serum Institute of India (SII) on Monday said it has started exporting 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.Developed in collaboration with the University of Oxford and Novavax's matrix-adjuvant, the R21/Matrix-M...
  7. Sonam Kapoor shares her 'simple routine' to get ready for presentations and meetings

    Sonam showed the steps of her "Get Ready With Me" video on Instagram.In the clip, she starts with moisturizer to massage her face, then uses serum and primer.Next, Sonam moves on to color correction, followed by applying some foundation and concealer. She sets her makeup with loose powder...
  8. SII will buy 20 percent stake in Integrimedical

    New Delhi, Vaccine maker Serum Institute of India (SII) on Friday said it is acquiring 20 per cent stake in Integrimedical to advance needle-free injection system technology.IntegriMedical has developed a US-patented needle-free injection system (N-FIS) that uses mechanical power to...
  9. SII invests in IntegriMedical to pioneer India's first needle-free technology

    With the investment, SII will acquire 20 per cent stake in Integrimedical. This investment will also accelerate the development and commercialization of N-FIS technology, making it more widely accessible to patients in India and across the world.“At SII, we are constantly looking for...
  10. Covishield side effects: Doctors' group urges government to review all Covid vaccines

    New Delhi: After pharmaceutical giant AstraZeneca admitted in a US court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday took an in-depth look at the safety of the Covishield vaccine manufactured by the Serum Institute of India. Considered from...
  11. Supreme Court adjourns hearing till May 17 on Serum Institute's plea challenging 2016 amendment to the Income Tax Act

    New Delhi: The Supreme Court on Monday adjourned to May 17 the plea by Serum Institute of India (SII) challenging the Bombay High Court order dismissing its plea against the 2016 amendments to the Income Tax Act. The petition was rejected. Had given.A bench of Chief Justice DY Chandrachud and...
  12. “It is a matter of pride for us”: Health Secretary on visiting OPV manufacturing unit in Netherlands

    AMSTERDAM [Netherlands], Union Health Secretary Apoorva Chandra on Wednesday visited the manufacturing unit of Bilthoven Biologicals in Utrecht, Netherlands, a branch of Pune-based Serum Institute of India that manufactures Oral Poly Vaccine (OPV). We have to visit an Indian company which is...
  13. Netherlands: Health Secretary visits Bilthoven Biologicals, discusses cooperation on production of oral polio vaccine

    New Delhi [India], Union Health Secretary Apoorva Chandra on Wednesday visited the manufacturing unit of global pharmaceutical company Bilthoven Biologicals in Utrecht, Netherlands. Additionally, the Union Health Secretary met CEO Juergen Quick in Bilthoven and Jeff de Klerk, CEO of Poonawala...
  14. summer beauty guide

    PN New Delhi [India], April 11: As the heat is rising, let's up our summer skincare, haircare and fragrance game! Get ready to embrace the sunny days ahead with our curated selection of products to meet all your skin care, hair care and body care needs! Whether you're relaxing on a sunny beach...